FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044460265> ?p ?o ?g. }

• W2044460265 endingPage "471" @default.
• W2044460265 startingPage "464" @default.
• W2044460265 abstract "The mean age of patients included in clinical trials does not reflect the current clinical practice for patients with B-cell non-Hodgkin lymphoma (B-NHL). We compared our outcomes for patients with B-NHL aged < 65 and > 65 years who were treated with 90-yttrium-ibritumomab tiuxetan therapy ((90)Y-IT).A total of 108 patients who had received (90)Y-IT according to the hospital protocol (ISCRTN36210045) were eligible. A quality of life (QoL) assessment using the Medical Outcomes Study short form 36-item survey was performed for patients aged > 65 years.Of the 108 patients, 43 were aged > 65 years (mean age, 73.4 years; men 46.15%); 37 had follicular NHL (86.0%). Also, 27 patients had previously undergone < 2 therapy regimens (62.8%). The mean follow-up period was 45.2 months. The mean progression-free survival (PFS) period was 71.3 months, and the mean overall survival was 78.2 months. The median values were not reached. The overall response rate was 90.5%, and a complete response was observed in 36 of the 43 patients aged > 65 years (85.7%). Neutropenia (43.3%) and thrombocytopenia (45.2%) were the most frequent grade 3 and 4 toxicities. Five patients required a red blood cell transfusion and 11, a platelet transfusion. Five patients aged > 65 years (11.6%) developed a second tumor. These outcomes were similar to those for the younger patients. The QoL assessment showed scores similar to those of general population for general health and social functioning.This is the largest cohort of NHL treated with RIT in a single institution in Spain. We observed a high response rate and prolonged PFS in patients with B-NHL, independent of patient age. Thus, consolidation RIT offers better outcomes with manageable toxicity." @default.
• W2044460265 created "2016-06-24" @default.
• W2044460265 creator A5001680179 @default.
• W2044460265 creator A5024169776 @default.
• W2044460265 creator A5058928024 @default.
• W2044460265 creator A5073093146 @default.
• W2044460265 creator A5081094099 @default.
• W2044460265 creator A5081558857 @default.
• W2044460265 creator A5081896872 @default.
• W2044460265 date "2015-08-01" @default.
• W2044460265 modified "2023-10-17" @default.
• W2044460265 title "Patients Older Than 65 Years With Non-Hodgkin Lymphoma Are Suitable for Treatment With 90Yttrium-Ibritumumab Tiuxetan: A Single-Institution Experience" @default.
• W2044460265 cites W1982790762 @default.
• W2044460265 cites W1996158315 @default.
• W2044460265 cites W2003443373 @default.
• W2044460265 cites W2031357333 @default.
• W2044460265 cites W2039275734 @default.
• W2044460265 cites W2054104934 @default.
• W2044460265 cites W2070830618 @default.
• W2044460265 cites W2080742973 @default.
• W2044460265 cites W2101648653 @default.
• W2044460265 cites W2110646221 @default.
• W2044460265 cites W2132443196 @default.
• W2044460265 cites W2140724555 @default.
• W2044460265 cites W2145301779 @default.
• W2044460265 cites W2155654259 @default.
• W2044460265 cites W2165299754 @default.
• W2044460265 cites W2167387655 @default.
• W2044460265 cites W2185305524 @default.
• W2044460265 cites W2203017689 @default.
• W2044460265 cites W2313142790 @default.
• W2044460265 cites W2322132547 @default.
• W2044460265 cites W2608724752 @default.
• W2044460265 cites W4239666205 @default.
• W2044460265 doi "https://doi.org/10.1016/j.clml.2015.02.025" @default.
• W2044460265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25823889" @default.
• W2044460265 hasPublicationYear "2015" @default.
• W2044460265 type Work @default.
• W2044460265 sameAs 2044460265 @default.
• W2044460265 citedByCount "8" @default.
• W2044460265 countsByYear W20444602652016 @default.
• W2044460265 countsByYear W20444602652018 @default.
• W2044460265 countsByYear W20444602652019 @default.
• W2044460265 countsByYear W20444602652021 @default.
• W2044460265 countsByYear W20444602652022 @default.
• W2044460265 crossrefType "journal-article" @default.
• W2044460265 hasAuthorship W2044460265A5001680179 @default.
• W2044460265 hasAuthorship W2044460265A5024169776 @default.
• W2044460265 hasAuthorship W2044460265A5058928024 @default.
• W2044460265 hasAuthorship W2044460265A5073093146 @default.
• W2044460265 hasAuthorship W2044460265A5081094099 @default.
• W2044460265 hasAuthorship W2044460265A5081558857 @default.
• W2044460265 hasAuthorship W2044460265A5081896872 @default.
• W2044460265 hasConcept C126322002 @default.
• W2044460265 hasConcept C141071460 @default.
• W2044460265 hasConcept C159110408 @default.
• W2044460265 hasConcept C159654299 @default.
• W2044460265 hasConcept C203014093 @default.
• W2044460265 hasConcept C2776146153 @default.
• W2044460265 hasConcept C2776694085 @default.
• W2044460265 hasConcept C2777058707 @default.
• W2044460265 hasConcept C2777063308 @default.
• W2044460265 hasConcept C2778476748 @default.
• W2044460265 hasConcept C2778515704 @default.
• W2044460265 hasConcept C2779338263 @default.
• W2044460265 hasConcept C2779951463 @default.
• W2044460265 hasConcept C2908647359 @default.
• W2044460265 hasConcept C542903549 @default.
• W2044460265 hasConcept C71924100 @default.
• W2044460265 hasConcept C99454951 @default.
• W2044460265 hasConceptScore W2044460265C126322002 @default.
• W2044460265 hasConceptScore W2044460265C141071460 @default.
• W2044460265 hasConceptScore W2044460265C159110408 @default.
• W2044460265 hasConceptScore W2044460265C159654299 @default.
• W2044460265 hasConceptScore W2044460265C203014093 @default.
• W2044460265 hasConceptScore W2044460265C2776146153 @default.
• W2044460265 hasConceptScore W2044460265C2776694085 @default.
• W2044460265 hasConceptScore W2044460265C2777058707 @default.
• W2044460265 hasConceptScore W2044460265C2777063308 @default.
• W2044460265 hasConceptScore W2044460265C2778476748 @default.
• W2044460265 hasConceptScore W2044460265C2778515704 @default.
• W2044460265 hasConceptScore W2044460265C2779338263 @default.
• W2044460265 hasConceptScore W2044460265C2779951463 @default.
• W2044460265 hasConceptScore W2044460265C2908647359 @default.
• W2044460265 hasConceptScore W2044460265C542903549 @default.
• W2044460265 hasConceptScore W2044460265C71924100 @default.
• W2044460265 hasConceptScore W2044460265C99454951 @default.
• W2044460265 hasIssue "8" @default.
• W2044460265 hasLocation W20444602651 @default.
• W2044460265 hasLocation W20444602652 @default.
• W2044460265 hasOpenAccess W2044460265 @default.
• W2044460265 hasPrimaryLocation W20444602651 @default.
• W2044460265 hasRelatedWork W2012409020 @default.
• W2044460265 hasRelatedWork W2124959401 @default.
• W2044460265 hasRelatedWork W2140133829 @default.
• W2044460265 hasRelatedWork W2147384423 @default.
• W2044460265 hasRelatedWork W2154715506 @default.
• W2044460265 hasRelatedWork W2407970965 @default.

• next